Holen Sie sich die Stockscreener-App
6.04
1.63%
-0.10
Handel nachbörslich:
6.05
0.010
+0.17%
Schlusskurs vom Vortag:
$6.14
Offen:
$6.01
24-Stunden-Volumen:
2,579
Relative Volume:
0.13
Marktkapitalisierung:
$54.64M
Einnahmen:
$23.84M
Nettoeinkommen (Verlust:
$-3.81M
KGV:
-12.08
EPS:
-0.5
Netto-Cashflow:
$-713.00K
1W Leistung:
+8.44%
1M Leistung:
+11.85%
6M Leistung:
-4.88%
1J Leistung:
+28.78%
1-Tages-Spanne:
$5.95
$6.11
1-Wochen-Bereich:
$5.50
$6.24
52-Wochen-Spanne:
$4.28
$7.60
Immucell Corp Stock (ICCC) Company Profile
Firmenname
Immucell Corp
Sektor
Branche
Telefon
(207) 878-2770
Adresse
56 EVERGREEN DR, PORTLAND, ME
Vergleichen Sie ICCC mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ICCC
Immucell Corp
|
6.04 | 55.54M | 23.84M | -3.81M | -713.00K | -0.50 |
|
VRTX
Vertex Pharmaceuticals Inc
|
454.96 | 115.62B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
746.36 | 79.10B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
851.42 | 52.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
391.17 | 51.72B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
200.67 | 42.00B | 447.02M | -1.18B | -906.14M | -6.1812 |
Immucell Corp Aktie (ICCC) Neueste Nachrichten
ImmuCell (NASDAQ:ICCC) Stock Passes Below 200-Day Moving AverageWhat's Next? - MarketBeat
ImmuCell Corporation (NASDAQ:ICCC) Expands Biological Cattle Protection - Kalkine Media
Insider Buying: te Boekhorst Paul Francis Olivier Acquires Additional Shares of ImmuCell Corp (ICCC) - GuruFocus
ImmuCell's Two-Product Edge in Cattle Health Fuels Growth - Finviz
Bull Run: Will ImmuCell Corporation stock maintain dividend yieldTrade Risk Report & Weekly Hot Stock Watchlists - moha.gov.vn
Will ImmuCell Corporation (IUL) stock benefit from sector leadershipJuly 2025 Sector Moves & Free Safe Capital Growth Stock Tips - Newser
Will ImmuCell Corporation stock continue dividend increasesMarket Sentiment Summary & Verified Technical Trade Signals - Newser
Will ImmuCell Corporation stock deliver consistent dividends2025 EndofYear Setup & Technical Confirmation Alerts - Newser
Is ImmuCell Corporation (IUL) stock a buy before earnings resultsJuly 2025 Volume & Free Technical Confirmation Trade Alerts - Newser
Is ImmuCell Corporation (IUL) stock a fit for income portfoliosJuly 2025 Market Mood & Daily Oversold Stock Bounce Ideas - Newser
ImmuCell (ICCC) director Tomsche buys shares worth $15,554 By Investing.com - Investing.com Canada
ImmuCell (ICCC) director Tomsche buys shares worth $15,554 - Investing.com
ImmuCell Corp Director David Scott Tomsche Buys Shares - TradingView
Chmn Tomsche Buys 3,266 ($15.6K) Of Immucell Corp [ICCC] - TradingView
ImmuCell Corp (ICCC) Q3 2025 Earnings Call Highlights: Navigating Challenges with Strategic ... By GuruFocus - Investing.com Canada
Will ImmuCell Corporation stock sustain high P E ratiosM&A Rumor & Safe Investment Capital Preservation Plans - newser.com
ICCC Stock Down Despite Y/Y Q3 Earnings Improvement & Margin Strength - Yahoo Finance
Why ImmuCell Corporation stock is a must watch in 2025Trade Risk Report & Daily Profit Maximizing Tips - newser.com
Will ImmuCell Corporation bounce back from current supportJuly 2025 Price Swings & Capital Efficiency Focused Strategies - newser.com
How to monitor ImmuCell Corporation with trend dashboards2025 Investor Takeaways & Safe Capital Growth Stock Tips - newser.com
ImmuCell Corporation (NASDAQ:ICCC) Q3 2025 Earnings Call Transcript - Insider Monkey
ImmuCell Corp. Experiences Valuation Adjustment Amidst Strong Yearly Performance Metrics - Markets Mojo
What catalysts could drive ImmuCell Corporation stock higherWeekly Risk Report & Community Consensus Trade Signals - newser.com
Earnings call transcript: ImmuCell Q3 2025 sees stock dip amid revenue fall - Investing.com Canada
ImmuCell Q3 2025 slides: Improved margins despite revenue dip, Re-Tain awaits FDA - Investing.com
How ImmuCell Corporation (IUL) stock valuation compares with sectorJuly 2025 Trends & Long-Term Growth Stock Strategies - Fundação Cultural do Pará
ImmuCell Corporation Reports Third Quarter 2025 Financial Results with Significant Year-Over-Year Improvements in Net Income and Gross Margin - Quiver Quantitative
[8-K] IMMUCELL CORP /DE/ Reports Material Event | ICCC SEC FilingForm 8-K - Stock Titan
Financial Review: CompuMed (OTCMKTS:CMPD) vs. ImmuCell (NASDAQ:ICCC) - Defense World
Multi asset correlation models including ImmuCell CorporationJuly 2025 Sentiment & Fast Exit Strategy with Risk Control - newser.com
ImmuCell to Announce Unaudited Financial Results for the Quarter Ended September 30, 2025 - The Manila Times
ImmuCell (NASDAQ: ICCC) schedules third-quarter results for Nov 13; call Nov 14 - Stock Titan
Finanzdaten der Immucell Corp-Aktie (ICCC)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.39%
1.90%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):